12
244 Tregs reactive to the p8E (Fig 3C) , p8G (Fig 3D) , 2.5HIP (Fig 3E) , and 6.9HIP (Fig 3F) 245 tetramers. These data support the idea that CNS1 deletion does not alter the relative 246 percentage of autoreactive Tconvs or Tregs within the pancreatic islets. Furthermore, 247 the Treg compartment within the pancreatic islets seem to be comprised of largely 248 tTregs.
249
250 No difference in glucose tolerance, time of T1D onset, or 251 disease incidence in NOD CNS1 -/-mice despite differences in 252 insulitis 253 The ultimate potential consequence of the effects of disruption of pTreg induction was 254 read out by the impact on T1D development in the NOD background. Female NOD and 255 NOD CNS1 -/-pancreata were collected at 6, 10, and 14 weeks of age for histology to 256 measure insulitis (Fig 4A) . Histological analysis of the isolated islets showed that there 257 was some increase in insulitis in NOD CNS1 -/-mice as early as 6 weeks and 10 weeks 258 of age in the CNS1 -/-mice. However, by 14 weeks, the time of initial development of 259 clinical diabetes in our colony, there was only a marginal difference in insulitis between 260 NOD and NOD CNS1 -/-females, suggesting that the deletion of CNS1 did not ultimately 261 lead to an increase in beta cell destruction. In fact, in younger pre-diabetic NOD CNS1 -/-262 female mice, normal glucose tolerance was maintained (Fic 4B-C). These results show 263 that the small differences in insulitis between NOD and NOD CNS1 -/-mice at earlier 264 ages were not consequential for either acute or chronic changes in blood glucose 265 control. Importantly, these early differences in insulitis did not influence the onset or 13 266 incidence of T1D in either female or male NOD CNS1 -/-mice, which was not statistically 267 different between the groups (Fig 4D) . 307 These results suggest that there may be a role for pTregs early in disease progression 308 but overtime, the tTregs dominate and control disease progression such that depending 309 on the colony and the degree of early beta cell damage, the resulting ability to control 310 disease and maintain normoglycemia may be different. In the case of our mice, tTregs 311 control disease progression preventing clinical disease, while in the other NOD Foxp3 15 312 CNS1 deletion model a clinical disease phenotype is evident in both male and female 313 mice.
314
315 Although many of the results we obtained are consistent with the previous NOD CNS1 -/-316 studies, there are a number of factors that could account for both earlier and more 317 severe insulitis in the CNS1 -/-mice described by Kissler and colleagues than those in 318 our colony. One difference between the different NOD CNS1 -/-mouse strains is that the 319 CNS1 deletion is not identical. Kissler and colleagues used sgRNAs that span a wider 320 region around the DNA than the ones we utilized. Thus, the resulting edit generated a 321 slightly larger 795 bp deletion (+1949 to +2743 from the Foxp3 transcriptional start site) 322 (unpublished information from Kissler) than was generated in the animals herein (+1976 323 to +2711). Whether these additional nucleotides might alter DNA binding of other 324 enhancer proteins remains unclear but might be impactful.
325
326 Perhaps the most likely difference between the two mouse models resides in the gut 327 microbiome or other environmental factors. There is extensive literature documenting 328 that innate microbial sensing and gut microbial constituents can shift T1D incidence, 329 explaining differences observed in diabetes incidence among animal facilities [54, 55] .
330 Specific differences in the gut microbial community of NOD males and females post-331 puberty also contribute to the differences in T1D incidence seen between the sexes 332 [56,57], and microbiome composition can be used to predict development of T1D [58] .
333 The gut microbiome might be linked to T1D due to the fact that the pLN is also a 334 draining site for microbial antigens [59] , and autoreactive cells have also shown cross-16 335 reactivity between microbial antigens and islet antigens [60, 61] . In fact, recent 336 characterization of the B6 CNS1 -/-mouse directly revealed that defects in gut pTreg 337 generation alter gut microbiome colonization [42, 43] . Since there is a change in gut 338 Tregs in both NOD CNS1 -/-models generated, the ability to observe a similar disease 339 phenotype in our NOD CNS1 -/-model might be masked by differences in gut 340 microbiome composition. Future studies that sequence and compare the microbiome of 341 NOD and NOD CNS1 -/-mice generated in the two facilities would be required to address 342 this issue directly.
343
344 In summary, our data suggest that tTregs play the dominant role in the control of islet-345 specific autoimmunity and subsequent development of diabetes. This conclusion is 346 supported by the observation that within the pancreatic islets, there are not many Tregs 347 that recognize tissue-specific, peripherally-generated autoantigens as detected by HIP 
